ID   SCCT9
AC   CVCL_VJ50
SY   SCC T9; T9
DR   cancercelllines; CVCL_VJ50
DR   CancerTools; 153667
DR   Cosmic; 2688678
DR   Wikidata; Q98129392
DR   Ximbio; 153667
RX   PubMed=24662767;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Sequence variation: Mutation; HGNC; 1787; CDKN2A; Simple; p.Pro48Leu (c.143C>T); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Gly13Asp (c.38G>A); ClinVar=VCV000012604; Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; 5173; HRAS; Simple; p.Asp107Gly (c.320A>G); Zygosity=Unspecified (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; 7881; NOTCH1; Simple; c.403+1G>A; Zygosity=Unspecified; Note=Splice donor mutation (PubMed=24662767).
CC   Sequence variation: Mutation; HGNC; 7882; NOTCH2; Simple; p.Cys1089Tyr (c.3266G>A); Zygosity=Unspecified (PubMed=24662767).
CC   Omics: Deep exome analysis.
CC   Derived from site: In situ; Right hand, skin; UBERON=UBERON_0001519.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 9,13
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 18,19
ST   D19S433: 14
ST   D21S11: 30.2,33.2
ST   D2S1338: 17,21
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 7,8
ST   D8S1179: 12,15
ST   FGA: 24
ST   TH01: 8,9.3
ST   TPOX: 9,11
ST   vWA: 18,19
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_LN09 ! MET-1
OI   CVCL_LN10 ! MET-2
OI   CVCL_LN11 ! MET-3
OI   CVCL_LN12 ! MET-4
OI   CVCL_LN13 ! PM-1 [Human oral dysplasia]
SX   Male
AG   45Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 30-01-24; Version: 11
//
RX   PubMed=24662767; DOI=10.1038/jid.2014.154; PMCID=PMC4753672;
RA   South A.P., Purdie K.J., Watt S.A., Haldenby S., den Breems N.Y.,
RA   Dimon M., Arron S.T., Kluk M.J., Aster J.C., McHugh A., Xue D.J.,
RA   Dayal J.H.S., Robinson K.S., Rizvi S.M.H., Proby C.M., Harwood C.A.,
RA   Leigh I.M.;
RT   "NOTCH1 mutations occur early during cutaneous squamous cell
RT   carcinogenesis.";
RL   J. Invest. Dermatol. 134:2630-2638(2014).
//
RX   PubMed=30202019; DOI=10.1038/s41467-018-06027-1; PMCID=PMC6131170;
RA   Inman G.J., Wang J., Nagano A., Alexandrov L.B., Purdie K.J.,
RA   Taylor R.G., Sherwood V., Thomson J., Hogan S., Spender L.C.,
RA   South A.P., Stratton M.R., Chelala C., Harwood C.A., Proby C.M.,
RA   Leigh I.M.;
RT   "The genomic landscape of cutaneous SCC reveals drivers and a novel
RT   azathioprine associated mutational signature.";
RL   Nat. Commun. 9:3667.1-3667.14(2018).
//
RX   PubMed=31336867; DOI=10.3390/ijms20143428; PMCID=PMC6678499;
RA   Hassan S., Purdie K.J., Wang J., Harwood C.A., Proby C.M.,
RA   Pourreyron C., Mladkova N., Nagano A., Dhayade S., Athineos D.,
RA   Caley M., Mannella V., Blyth K., Inman G.J., Leigh I.M.;
RT   "A Unique panel of patient-derived cutaneous squamous cell carcinoma
RT   cell lines provides a preclinical pathway for therapeutic testing.";
RL   Int. J. Mol. Sci. 20:3428.1-3428.26(2019).
//